Edgar Antonio Estrella Parra

Dr. Edgar Antonio Estrella Parra


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
Nadia RiveroNadia Rivero
Nadia Rivero
EZEmmanuel Alejandro Zepeda-Arzate
Emmanuel Alejandro Zepeda-Arzate
SCSelma Karime Castillo-Vazquez
Selma Karime Castillo-Vazquez
PPPatrick Fleischmann de la Parra
Patrick Fleischmann de la Parra
JHJessica Hernández-Pineda
Jessica Hernández-Pineda
CVCarlos Verjan
Carlos Verjan
Aging is the result of the accumulation of a wide variety of molecular and cellular damages over time, meaning that “the more damage we accumulate, the higher the possibility to develop age-related diseases”. Therefore, to reduce the incidence of such diseases and improve human health, it becomes important to find ways to combat such damage. In this sense, geroprotectors have been suggested as molecules that could slow down or prevent age-related diseases. On the other hand, nutraceuticals are another set of compounds that align with the need to prevent diseases and promote health since they are biologically active molecules (occurring naturally in food) that, apart from having a nutritional role, have preventive properties, such as antioxidant, anti-inflammatory and antitumoral, just to mention a few. Therefore, in the present review using the specialized databases Scopus and PubMed we collected information from articles published from 2010 to 2023 in order to describe the role of nutraceuticals during the aging process and, given their role in targeting the hallmarks of aging, we suggest that they are potential geroprotectors that could be consumed as part of our regular diet or administered additionally as nutritional supplements.

28 September 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
CVCarlos Verjan
Carlos Verjan
EZEmmanuel Alejandro Zepeda-Arzate
Emmanuel Alejandro Zepeda-Arzate
JCJosé Alberto Santiago de la Cruz
José Alberto Santiago de la Cruz
EPEdgar Antonio Estrella Parra
Edgar Antonio Estrella Parra
Nadia RiveroNadia Rivero
Nadia Rivero
Ischemic stroke (IS) is one of the leading causes of mortality worldwide. It is characterized by the partial or total occlusion of arteries that supply blood to the brain, leading to the death of brain cells. In recent years, natural bioactive compounds (NBCs) have shown properties that ameliorate the injury after IS and improve the patient’s outcome, which has proven to be a potential therapeutic strategy due to their neuroprotective effects. Hence, in the present study, we use both systems pharmacology and chemoinformatic analyses to identify which NBCs have the most potential to be used against IS in clinics. Our results identify that flavonoids and terpenoids are the most studied NBCs, and, mainly, salidrosides, ginkgolides A, B, C, and K, cordycepin, curcumin, baicalin, resveratrol, fucose, and cannabidiol, target the main pathological processes occurring in IS. However, the medicinal chemistry properties of such compounds demonstrate that only six fulfill such criteria. However, only cordycepin and salidroside possess properties as leader molecules, suggesting that these compounds may be considered in developing novel drugs against IS.

12 May 2024 in Molecules
Verified
Journal Article
Open access
PDF file
EFEdgar Flores-Soto
Edgar Flores-Soto
BRBianca Romero-Martinez
Bianca Romero-Martinez
HSHector Solis-Chagoyan
Hector Solis-Chagoyan
EPEdgar Antonio Estrella Parra
Edgar Antonio Estrella Parra
JAJose G. Avila-Acevedo
Jose G. Avila-Acevedo
LMLuis M Montaño
Luis M Montaño
The Cupressaceae family includes species considered to be medicinal. Their essential oil is used for headaches, colds, cough, and bronchitis. Cedar trees like Chamaecyparis lawsoniana (C. lawsoniana) are commonly found in urban areas. We investigated whether C. lawsoniana exerts some of its effects by modifying airway smooth muscle (ASM) contractility. The leaves of C. lawsoniana (363 g) were pulverized mechanically, and extracts were obtained by successive maceration 1:10 (w:w) with methanol/CHCl3. Guinea pig tracheal rings were contracted with KCl, tetraethylammonium (TEA), histamine (HIS), or carbachol (Cch) in organ baths. In the Cch experiments, tissues were pre-incubated with D-600, an antagonist of L-type voltage-dependent Ca2+ channels (L-VDCC) before the addition of C. lawsoniana. Interestingly, at different concentrations, C. lawsoniana diminished the tracheal contractions induced by KCl, TEA, HIS, and Cch. In ASM cells, C. lawsoniana significantly diminished L-type Ca2+ currents. ASM cells stimulated with Cch produced a transient Ca2+ peak followed by a sustained plateau maintained by L-VDCC and store-operated Ca2+ channels (SOCC). C. lawsoniana almost abolished this last response. These results show that C. lawsoniana, and its active metabolite quercetin, relax the ASM by inhibiting the L-VDCC and SOCC; further studies must be performed to obtain the complete set of metabolites of the extract and study at length their pharmacological properties.

Verified
Journal Article
Open access
PDF file
Oscar Salvador Barrera-VázquezOscar Salvador Barrera-Vázquez
Oscar Salvador Barrera-Vázquez
JSJosé Santiago
José Santiago
Nadia RiveroNadia Rivero
Nadia Rivero
EPEdgar Antonio Estrella Parra
Edgar Antonio Estrella Parra
GMGenaro Morales-Paoli
Genaro Morales-Paoli
CVCarlos Verjan
Carlos Verjan
Parkinson’s disease (PD) is the second most common neurodegenerative disease in older individuals worldwide. Pharmacological treatment for such a disease consists of drugs such as monoamine oxidase B (MAO-B) inhibitors to increase dopamine concentration in the brain. However, such drugs have adverse reactions that limit their use for extended periods; thus, the design of less toxic and more efficient compounds may be explored. In this context, cheminformatics and computational chemistry have recently contributed to developing new drugs and the search for new therapeutic targets. Therefore, through a data-driven approach, we used cheminformatic tools to find and optimize novel compounds with pharmacological activity against MAO-B for treating PD. First, we retrieved from the literature 3316 original articles published between 2015–2021 that experimentally tested 215 natural compounds against PD. From such compounds, we built a pharmacological network that showed rosmarinic acid, chrysin, naringenin, and cordycepin as the most connected nodes of the network. From such compounds, we performed fingerprinting analysis and developed evolutionary libraries to obtain novel derived structures. We filtered these compounds through a docking test against MAO-B and obtained five derived compounds with higher affinity and lead likeness potential. Then we evaluated its antioxidant and pharmacokinetic potential through a docking analysis (NADPH oxidase and CYP450) and physiologically-based pharmacokinetic (PBPK modeling). Interestingly, only one compound showed dual activity (antioxidant and MAO-B inhibitors) and pharmacokinetic potential to be considered a possible candidate for PD treatment and further experimental analysis.

31 May 2023
Verified
Book Chapter
Open access
MSMaría Elizbeth Alvarez Sánchez
María Elizbeth Alvarez Sánchez
EOErick Nolasco Ontiveros
Erick Nolasco Ontiveros
RARodrigo Arreola
Rodrigo Arreola
AGAdriana Montserrat Espinosa González
Adriana Montserrat Espinosa González
ABAna María García Bores
Ana María García Bores
EPEdgar Antonio Estrella Parra
Edgar Antonio Estrella Parra
The lipids are essential compounds of cells, with biochemical and structural properties. Lipids are classified according to their chain length or saturation levels and biogenesis. Lipidomics is a spectroscopic and spectrometric technique, like Mass Spectrometry and Nuclear Magnetic Resonance, as well as bioinformatics to quantify and characterize the lipid profile. Lipidomics enables the fundamental understanding of lipid biology, the identification of drug targets for therapy, and the discovery of lipid biomarkers of disease cohorts. Therefore, lipidomics allows knowing the diagnosis and clinical follow-up in medical therapy towards any disease. In this way, the lipid profile allows us to monitor the administration of a clinical treatment and assertively diagnose human diseases.

20 August 2025 in Records of Natural Products
Verified
Journal Article
Closed access
IVIsrael Valencia
Israel Valencia
AVAna K. Villagómez-Guzmán
Ana K. Villagómez-Guzmán
AGAna María García-Bores
Ana María García-Bores
MLMiriam Arlette López-Pérez
Miriam Arlette López-Pérez
EPEdgar Antonio Estrella Parra
Edgar Antonio Estrella Parra
CHClaudia Tzasna Hernandez
Claudia Tzasna Hernandez
Bioassay-guided fractionation of extracts of aerial parts from Lippia callicarpifolia via chromatographic techniques led to the isolation of two D:C-friedours-7-ene compounds, namely D:C-3-oxo-friedours-7-en-28-oic acid (1) and a new callicarpifolic acid (2). Furthermore, additional known compounds, β-sitosterol glucoside (3) and genkwanin (4) were also identified. The structures of the natural products were established by 1D and 2D NMR, IR, and spectrometric analyses. In the antifungal assays, Fusarium sporotrichioides NRLL was sensitive to compounds 1 and 4 in the concentration range of 0.25–1 mg/mL. The docking investigation revealed high inhibition of the trichodiene synthase enzyme by compound 4.